• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Jul7
Distribution Plan(EST)

Cash dividend 0.1421 USD

Jun27
Distribution Plan(EST)

Cash dividend 0.1421 USD

Distribution Plan(EST)

Cash dividend 0.1421 USD

View More

Event Tracking

Dec26
ABL Bio and Eli Lilly Enter into $40 Million Prepayment and Long-term Collaboration Agreement
04:40
Eli Lilly to Participate in the 44th Annual J.P. Morgan Healthcare Conference
02:20
Eli Lilly Announces Positive Results from Phase 3 Maintenance Trial of its Oral Weight-Loss Drug Orforglipron
00:00
Dec25
21st Century Business Herald reports Lilly's GLP-1 drug tirzepatide quarterly sales exceed $10 billion, on track to surpass $35 billion for the year
19:51
Competitor News: Novo Nordisk's Oral Weight-Loss Drug Approved, Intensifying GLP-1 Market Competition
12:33
GLOBALT Investments LLC GA Increased Holdings in Johnson & Johnson in Q3
10:54